Your session is about to expire
← Back to Search
Vagus Nerve Stimulation
transcutaneous auricular vagus nerve stimulation for Infant Development
Phase < 1
Waitlist Available
Led By Bashar Badran, PhD
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30min treatment session
Awards & highlights
Study Summary
This study is evaluating whether a type of nerve stimulation may help improve feeding in premature infants.
Eligible Conditions
- Poor Appetite
- Infant Development
- Vagus Nerve Stimulation
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30min treatment session
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30min treatment session
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Neuroplasticity as Measured by the Change in White Matter Tract Integrity Via Fractional Anisotropy
Number of Infants Who Took All Feeds by Mouth (Responders)
ml/kg/d Increase Over 7d During taVNS
Secondary outcome measures
Number of Episodes of Bradycardia
Number of Treatment Sessions With Sustained Increase in 'Neonatal and Infant Pain Scale' (NIPS) Scores During taVNS
Trial Design
2Treatment groups
Experimental Treatment
Group I: taVNS twice dailyExperimental Treatment1 Intervention
taVNS paired with bottle feeding twice daily for 2-3 weeks
Group II: taVNS once dailyExperimental Treatment1 Intervention
taVNS paired with bottle feeding once daily for 2-3 weeks
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
transcutaneous auricular vagus nerve stimulation
2022
Completed Early Phase 1
~100
Find a Location
Who is running the clinical trial?
Medical University of South CarolinaLead Sponsor
933 Previous Clinical Trials
7,394,600 Total Patients Enrolled
1 Trials studying Infant Development
3 Patients Enrolled for Infant Development
National Institute of General Medical Sciences (NIGMS)NIH
269 Previous Clinical Trials
247,077 Total Patients Enrolled
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,965 Previous Clinical Trials
2,672,762 Total Patients Enrolled
6 Trials studying Infant Development
776 Patients Enrolled for Infant Development
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger